RORC and acute myeloid leukemia: To better assess the effectiveness of CLO-TOR as a potential therapeutic combination in AML, we examined the activation of the PI3K/Akt/mTOR pathway in 12 AML patient samples isolated from bone marrow or peripheral blood.